antifungal activity of selenium nanoparticles synthesized by bacillus species msh-1 against aspergillus fumigatus and candida albicans

results the results of energy-dispersive x-ray demonstrated that the purified nps consisted of only se. in addition, transmission electron micrographs showed that 120- to 140-nm spherical se nps were the most common. an antifungal assay was performed with a standard clinical and laboratory standards institute broth microdilution method. minimum inhibitory concentration (mic) measurements of the antifungal activity of the se nps against c. albicans (70 μg/ml) and a. fumigatus (100 μg/ml) showed that yeast cells were more sensitive than mold cells. conclusions the mics against a. fumigatus (100 μg/ml) and c. albicans (70 μg/ml) showed that biogenic se nps are useful antifungal agents. objectives in the present study, the antifungal activity of biogenic selenium nanoparticles (se nps) against aspergillus fumigatus and candida albicans was investigated. materials and methods se-reducing bacteria previously identified as bacillus sp. msh-1 were used for the intracellular biosynthesis of elemental se nps. the shape, size, and purity of the extracted nps were determined with various instrumental techniques. the nanoparticles antifungal characterization mainly derives from the following pathways: (i) to generate sustained flux of nano-ions from the compounds that deposited on special substrates or imbedded in colloidal or semisolid matrices. (ii) to transport active those ions to sensitive targets on plasma membrane of fungi. background fungal infections affect various parts of the body and can be difficult to treat. aspergillus infection causes a spectrum of diverse diseases particularly in lung according to host immunity. the two major entities are invasive pulmonary aspergillosis and chronic pulmonary aspergillosis. candida infections can be superficial or invasive. superficial infections often affect the skin or mucous membranes. however, invasive fungal infections are often life-threatening. advances in nanotechnology have opened new horizons in nanomedicine, allowing the synthesis of nanoparticles that can be assembled into complex architectures. novel studies and technologies are devoted to understanding the mechanisms of disease for the design of new drugs.